In what is projected to be one of the largest IPOs in history, the AI giant, Anthropic, has taken the first step in holding an IPO, with AI in bio/pharmaceutical development a key component in its ...

Sun Pharma’s pending $11.75-billion acquisition of Organon was one of the largest M&A in 2026 and is aligned with its strategy of in part diversifying into innovator drugs, a step taken by other ...

Eli Lilly and Company has broken ground on a new $5-billion manufacturing facility in Goochland County, Virginia, west of Richmond, Virginia, which will produce active pharmaceutical ingredients (APIs ...

An important recent trend in parenteral drugs is the development of subcutaneous (i.e., under the skin) delivery through injectables for bio/pharmaceuticals that were administered intravenously (IV).

The continued ascent of biologics in the industry’s pipeline and in commercial products bodes well for CDMOs of biologics, but how is the industry trending overall in terms of biomanufacturing ...

The Pharmaceutical Research and Manufacturers of America (PhRMA), the industry association representing innovator drug companies in the US, has filed a complaint in a federal district court asserting ...